Dr. Muneeb Shah’s Remedy Raises $20M Series A Round As Investors Double Down On Clinical Skincare

Existing investor Norwest Venture Partners and new investor Sonoma Brands joined L Catterton in the round. The investors were drawn to 2-year-old Remedy’s performance—it’s been profitable since year one and is on track to hit $50 million in sales this year, according to Shah—as well as its position in a relatively underserved segment of the market, bringing clinically grounded skincare to mass retail. Shah’s social media audience was another attraction. He’s amassed more than 21 million followers across TikTok, Instagram and YouTube, giving Remedy a built-in audience that few emerging skincare brands can match. Mindful of intellectual property, Remedy has complete ownership of its formulas. The brand is putting its fresh capital toward clinical research, product development and organizational capabilities. Shah expects L Catterton’s experience scaling consumer brands to be valuable as his brand grows. Click here to secure Early Bird tickets to Dealmaker Summit running Nov. 9 to 10 in London.